Determination of Plasma Tissue Factor Antigen and Tissue Factor-Bearing Microparticles Activity in Healthy Subjects
Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 19, Issue 3
Abstract
Background: Tissue factor (TF) is an integral membrane protein, normally separated from the blood by the vascular endothelium, which plays a key role in the initiation of blood coagulation. TF is present in plasma in various forms, including microparticles (MPs) and alternatively spliced TF. MPs are small (< 1 μm) membrane vesicles generated by activated or apoptotic cells. Levels of TF antigen (TF-Ag) and tissue factor-bearing microparticles (MP-TF) activity from different origins are thought to be associated with hypercoagulable states. The aim of the present study was to determine the reference range for plasma levels of TF-Ag and MP-TF activity in healthy subjects.Methods: To establish the reference range for plasma levels of TF-Ag and MP-TF activity and study the impact of sex and age we recruited 120 healthy subjects of Bulgarian nationality aged between 18 and 65. The selection criteria for the reference group were made to comply with the generally approved recommendations of the International Federation of Clinical Chemistry (IFCC). Clinical and routine hematological, biochemical and coagulation tests were performed to assess their health status. Plasma levels of TFAg were determined using ELISA and MP-TF activity by means of bio-immunoassay.Results: The reference range given as 95% of the measured values was defined for TF-Ag plasma levels with 59.2 pg/ml (90% CI: 50.9 -68.2) to 250.9 pg/ml (90% CI: 234.6- 267.0) and for plasma levels of MP-TF activity with 0.03 pg/ml (90% CI: 0.01-0.06) to 0.47 pg/ml (90% CI: 0.43-0.50). We found no sex-related differences in plasma TF-Ag and MP-TF activity (p > 0.05), which obviates the need for separate reference intervals for men and women. Single-factor dispersion analysis found no age dependency of plasma levels for TF-Ag and MP-TF activity (p > 0.05) in the age range 18-65.Conclusion: The reference values for TF-Ag and MP-TF activity plasma levels calculated according to the type of distribution of results can be used as baseline criteria in clinical laboratory studies and for clinical purposes. Tissue factor (TF) is a transmembrane glycoprotein that is essential for hemostasis. It binds the coagulation serine protease factor VII/VIIa (FVII/VIIa) to form a bimolecular complex that functions as the primary initiator of coagulation in vivo [1]. TF is expressed in the vascular adventitia, in astroglial cells, in organ capsules and is found in lungs and placenta at relatively high concentrations [2]. Unstimulated monocytes and endothelial cells do not express tissue factor but can be induced to express tissue factor on their surface under certain conditions, primarily by inflammatory cytokines and endotoxin [3-5]. Under normal circumstances cells in contact with blood do not express physiologically active TF. When mechanical or chemical damage of the vascular wall occurs, subendothelial TF is expressed/exposed to blood and binds plasma factor VIIa. The TF/factor VIIa complex initiates linked, enzymatic reactions that culminate in the generation of thrombin and the subsequent conversion of fibrinogen to fibrin [2]. Thrombin also activates platelets by cleavage of proteaseactivated receptors (PARs) [6]. TF is constitutively expressed at high levels in adventitial fibroblasts of the vessel wall and this facilitates the rapid activation of the coagulation cascade after injury [7,8]. Very low levels of TF are present in the blood of healthy individuals [9]. This so-called circulating TF is mostly present in the form of microparticles (MPs), which are submicron membrane vesicles (<1μm) derived from apoptotic and/or activated cells [10]. MPs have phospholipid surface which can assemble coagulation factors, resulting in procoagulant potential 2. The role of circulating TF in healthy individuals has not been defined [11]. Blood also contains soluble forms of TF, including alternatively spliced TF [11]. Many studies have shown that levels of TF and MP-TF activity are increased in various diseases, including cancer, sepsis, cardiovascular diseases and diabetes [12-16]. Prothrombotic tendency is characteristic of solid tumors. Cancer is associated with a four-fold increase in the risk for venous thromboembolism (VTE) and chemotherapy further increases this risk to between six and seven-fold compared with that in the general population [17]. Overall, the occurrence of VTE in patients with cancer is associated with increased morbidity and mortality [18]. Tissue factor (TF) has been considered a crucial role in the cancer VTE, especially the expression of TF on microparticles (MPs) which were released from tumor cells in the circulating blood [19, 20].
Authors and Affiliations
Stoencheva S, Deneva T, Beleva E, Grudeva Popova Zh, Popov V
Keywords
Related Articles
- EP ID EP621724
- DOI 10.26717/BJSTR.2019.19.003292
- Views 158
- Downloads 0
The Benefits of Long Duration Ultrasound
Emerging clinical evidence demonstrates that ultrasound dose timing (i.e. daily treatment) and duration significantly impact benefits and treatment results. Therapeutic wearable ultrasound for multi-hour therapy has been...
Incidence and Severity of Virus Diseases of Okra (Abelmoschus esculentus L. Moench) under Different Mulching Types
An experiment was carried out to assess the effect of mulching material on the incidence and severity of some common virus diseases on Okra NH 47-4 (Abelmoschus esculentus L Moench). The treatments were (3X4) factorial d...
Rainy Days, Geographic Coordinates, Vitamin D, Silicon, Selenium and CHD in Finland in 1962-2014
Background: Higher cardiac as also general mortality in eastern regions of Finland than in the west, has been decades without satisfactory explanation. High number of annual rainy days (RD) and lower serum vitamin D valu...
The Effect of Local Anesthesia (Lidocaine 2%) with Epinephrine (1:100,000) On Blood Pressure Level of Hypertensive Patients Reported To a Tertiary Care Hospital, Peshawar, Pakistan
Objective: The objective of the study was to evaluate the effect of local anesthesia (Lidocaine) with epinephrine (1:100000) on blood pressure level and medicine used by hypertensive patients having Prehypertension, stag...
Proteomics - The Future of Periodontal Diagnostics
Recent advances of proteomic meth¬odologies have opened new opportunities to obtain relevant information on normal and abnormal processes occurring in the human body. Identifying unique patterns of protein expression, or...